SCS-7773874-9/21/1

Sanofi Aventis Recherche & Developpement — FEI 3004883328

Refusal Details

Date
December 31, 2019
Country
France
Product Category
Drugs and Biologics
Product Code
61PCA31 GLIMEPIRIDE (ANTI-DIABETIC)
Charges
118,3280